Methods to enable insertion of large fragments of DNA into genomes of live cells at library scale
The method enables the efficient insertion of large DNA payloads into cellular genomes, overcoming existing limitations by using a library of integration cassettes and large insert constructs, allowing for precise genetic modifications and enhanced biological functions in live cells.
Patent Information
- Application Number
- PCT/US2024/029481
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-16
- Filing Date
- 2024-05-15
- Publication Date
- 2024-11-21
AI Technical Summary
Current methods for nucleic acid-guided nuclease editing, such as CRISPR, are limited in their ability to insert large DNA payloads greater than 100 base pairs into cellular genomes at a library scale, hindering precise and targeted changes to gene sequences in live cells.
The development of compositions and methods that allow for the multiplexed insertion of large DNA payloads into cellular genomes using a library of integration cassettes and large insert constructs, enabling the insertion of biologically important moieties like eukaryotic promoters and biological pathways into diverse target loci in a population of cells without the need for a selection marker integration event.
Enables efficient integration of large DNA inserts into various loci in cellular genomes, facilitating changes to existing genes, enhancing biological functions, and expanding the enzymatic repertoire of host cells, while maintaining cell viability and identifying successful integration and gene expression sites.
Smart Images

Figure 000040 
Figure 000041 
Figure 000042
Abstract
Description
METHODS TO ENABLE INSERTION OF LARGE FRAGMENTS OF DNA INTO GENOMES OF LIVE CELLS AT LIBRARY SCALECROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority to U.S. Provisional Application No. 63 / 502,502, filed May 16, 2023, the contents of which are hereby incorporated by reference in their entirety.FIELD OF THE INVENTION
[0002] The present disclosure relates to compositions and methods for delivery of large DNA payloads into various loci in the genomes of a population of live cells at library scale.BACKGROUND OF THE INVENTION
[0003] In the following discussion certain articles and methods will be described for background and introductory purposes. Nothing contained herein is to be construed as an “admission” of prior art. Applicant expressly reserves the right to demonstrate, where appropriate, that the articles and methods referenced herein do not constitute prior art under the applicable statutory provisions.
[0004] The ability to make precise, targeted changes to the genome of living cells has been a long-standing goal in biomedical research and development. Recently, various nucleases have been identified that allow for manipulation of gene sequences; hence gene function. The nucleases include nucleic acid-guided nucleases (i.e., CRISPR nucleases), which enable researchers to generate permanent edits in live cells; however, currently, the payload that can be inserted — particularly at library scale — is approximately 100 base pairs or less.
[0005] There is thus a need in the art of nucleic acid-guided nuclease editing for improved methods and compositions to facilitate insertion of payloads greater than 100 base pairs into a cellular genome. Being able to efficiently drive insertion of large payloads of DNA at library scale into model hosts such as E. coli and S. cerevisiae has high value in a broad variety of applications. The present disclosure addresses this need.SUMMARY OF THE INVENTION
[0006] This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. Other features, details, utilities, and advantages of the claimed subject matter will be apparent from the following written Detailed Description including those aspects illustrated in the accompanying drawings and defined in the appended claims.
[0007] The present disclosure relates to compositions and high-throughput methods that allow one to perform nucleic acid-guided nuclease or nickase fusion editing to embed large DNA payloads into diverse target loci in a population of cells in a multiplexed manner. The large payloads include biologically important moieties such as eukaryotic promoters, one or more genes, and partial or entire biological pathways for, e.g., building useful base strains of microbes. Until the present disclosure, editing with large inserts typically involved co-transformation of a gRNA and a linear repair template, which does not allow for editing a population of cells at library scale. Here, the methods comprise first designing and synthesizing a library of integration cassettes and inserting the integration cassettes into a vector backbone to create a library of integration vectors. The integration cassettes (and thus the integration vectors) target different loci in the cellular genome for insertion of the large insert constructs.
[0008] The large insert constructs are designed to comprise the large payloads of interest (e.g., a promoter library, heterologous genes or biological pathways) most often including one or more edits to the PAM (protospacer adjacent motif) or spacer, and the large insert constructs also comprise regions homologous to the integration cassettes. Once the integration vectors and large insert constructs are designed and synthesized, the integration vectors are linearized and combined with the large insert constructs to create a library of editing vectors, where each vector comprises an integration cassette with a large insert construct embedded therein. The library of editing vectors then is used to transform the population of cells. Once conditions are provided for editing to occur, the result is a population of edited cells where the large insert constructs are inserted into various loci in the genomes of the population these cells. Editing the cells in the population with suchlarge inserts allows one to 1) change existing genes and, 2) enhance the biological function of gene products or 3) provides facile methods for integrating heterologous genes or pathways that expand the enzymatic repertoire of the host cell. Analyzing the edited cells allows one to 1) identify loci in the population of cells where a large insert can be integrated into the genome while maintaining the viability of the cells, and 2) identify loci in the population of cells where a large insert increases production of one or more proteins; that is, one can “survey” many sites in the cellular genome for both successful integration and for, e.g., successful gene expression and / or protein production. Thus, the present description provides a nuclease assisted method that allows integration of a library of large DNA inserts into the genomes of a population of cells scale without a corresponding selection marker integration event.
[0009] In some aspects, the present disclosure provides a method for multiplex insertion of large DNA inserts into a population of cells comprising the steps of: designing and synthesizing a library of integration cassettes with first and second primer handles, wherein each integration cassette comprises 1) a gRNA comprising a scaffold region capable of interacting with a nucleic acid-guided nuclease or nickase fusion enzyme and a guide sequence capable of hybridizing to a genomic target locus of interest; and 2) two portions of a donor DNA, comprising from 5' to 3': a first region of homology to the target locus of interest, the first "primer handle", the second "primer handle", and a second region of homology to the target locus of interest; amplifying the library of integration cassettes; inserting the library of integration cassettes into a vector backbone to create an integration vector library; linearizing the integration vectors in the integration vector library using the primer handles; designing and synthesizing a library of large insert constructs, wherein each large insert construct comprises a large insert of interest flanked by regions of homology to the integration cassettes; amplifying the library of large insert constructs; assembling the integration vector library and the large insert constructs creating a library of editing cassettes; transforming the population of cells with the library of editing cassettes; and providing conditions to facilitate editing in the population of cells by the editing cassettes.
[0010] In some aspects, the present disclosure provides a method for multiplex insertion of large DNA inserts into a population of cells comprising the steps of: obtaininga library of editing cassettes, wherein each editing cassette comprises 1) a first portion encoding a gRNA comprising a scaffold region capable of interacting with a nucleic acid- guided nuclease or nickase fusion enzyme and a guide sequence capable of hybridizing to a genomic target locus of interest; and 2) three portions of a donor DNA, comprising: a first region of homology to the genomic target locus of interest, a second region of homology to the genomic target locus of interest, and a large insert of interest flanked by the first and second regions of homology; transforming the population of cells with the library of editing cassettes; and providing conditions to facilitate editing in the population of cells by the editing cassettes. In some embodiments, the library of editing cassettes is obtained by assembling an integration vector library and a library of large insert constructs, wherein the integration vector library comprises integration cassettes each comprising 1) the first portion encoding the gRNA; and 2) two portions of the donor DNA, comprising from 5' to 3': the first region of homology to the target locus of interest and the second region of homology to the target locus of interest; and wherein the library of large insert constructs each comprise a large insert of interest flanked by regions of homology to the integration cassettes.
[0011] In some embodiments of any of the foregoing or related aspects, the large insert of interest is at least about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments of any of the foregoing or related aspects, the large insert of interest is at most about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments of any of the foregoing or related aspects, the large insert of interest is about 150 to about 250, about 200 to about 300, about 250 to about 350, about 300 to about 400, about 350 to about 450, about 400 to about 500, about 450 to about 550, about 500 to about 600, about 550 to about 650, about 600 to about 700, about 650 to about 750, about 700 to about 800, about 750 to about 850, about 800 to about 900, about 850 to about 950, about 900 to about 1000, about 950 to about 1050, about 1000 to about 1100, about 1050 to about 1150, about 1100 to about 1200, about 1150 to about 1250, about 1200 to about 1300, about 1250 to about 1350, about 1300 to about 1400, about 1350 to about 1450, about 1400 to about 1500, about 1450 to about 1550, about 1500 to about 1600, about 1550 to about 1650, about 1600 to about 1700, about 1650 to about 1750, about 1700 to about 1800, about 1750 to about1850, about 1800 to about 1900, about 1850 to about 1950, about 1900 to about 2000, about 1950 to about 2050, about 2000 to about 2100, about 2050 to about 2150, about 2100 to about 2200, about 2150 to about 2250, about 2200 to about 2300, about 2250 to about 2350, about 2300 to about 2400, about 2350 to about 2450, about 2400 to about 2500, about 2450 to about 2550, about 2500 to about 2600, about 2550 to about 2650, about 2600 to about 2700, about 2650 to about 2750, about 2700 to about 2800, about 2750 to about 2850, about 2800 to about 2900, about 2850 to about 2950, about 2900 to about 3000, about 2950 to about 3050, about 3000 to about 3100, about 3050 to about 3150, about 3100 to about 3200, about 3150 to about 3250, about 3200 to about 3300, about 3250 to about 3350, about 3300 to about 3400, about 3350 to about 3450, about 3400 to about 3500, about 3450 to about 3550, about 3500 to about 3600, about 3550 to about 3650, about 3600 to about 3700, about 3650 to about 3750, about 3700 to about 3800, about 3750 to about 3850, about 3800 to about 3900, about 3850 to about 3950, about 3900 to about 4000, about 3950 to about 4050, about 4000 to about 4100, about 4050 to about 4150, about 4100 to about 4200, about 4150 to about 4250, about 4200 to about 4300, about 4250 to about 4350, about 4300 to about 4400, about 4350 to about 4450, about 4400 to about 4500, about 4450 to about 4550, about 4500 to about 4600, about 4550 to about 4650, about 4600 to about 4700, about 4650 to about 4750, about 4700 to about 4800, about 4750 to about 4850, about 4800 to about 4900, about 4850 to about 4950, or about 4900 to about 5000 bp long. In some embodiments of any of the foregoing or related aspects, the editing cassettes are in circular vectors. In some embodiments of any of the foregoing or related aspects, the editing cassettes are in linear vectors.
[0012] These aspects and other features and advantages of the invention are described below in more detail.BRIEF DESCRIPTION OF THE DRAWINGS
[0013] The foregoing and other features and advantages of the present invention will be more fully understood from the following detailed description of illustrative embodiments taken in conjunction with the accompanying drawings in which:
[0014] FIG. 1 is a simple process diagram for creating editing vectors comprising large stretches of heterologous DNA at library scale for editing a population of cells.
[0015] FIG. 2A is a simplified representation of a library of three different integration cassettes.
[0016] FIG. 2B is a simplified representation of a method of inserting one of the integration cassettes shown in FIG. 2A into a vector backbone.
[0017] FIG. 2C is a simplified representation of an integration cassette having been inserted into a vector backbone to create an integration vector.
[0018] FIG. 2D is a simplified representation of the integration vector of FIG. 2C that has been linearized.
[0019] FIG. 2E is a simplified representation of a library of large insert constructs.
[0020] FIG. 2F is a simplified representation of inserting one of the large insert constructs from FIG. 2E into the linearized integration vector of FIG. 2D.
[0021] FIG. 2G is a simplified representation of one editing vector (from a library of editing vectors) created via the methods described herein and shown in FIGs. 2A - 2F.
[0022] FIG. 2H is a simplified representation of the large insert construct integrated into a locus in a cellular genome showing positions of primers that may be used to interrogate the insertion sites and the large insert construct.
[0023] It should be understood that the drawings are not necessarily to scale, and that like reference numbers refer to like features.DETAILED DESCRIPTION
[0024] All of the functionalities described in connection with one embodiment of the methods, devices or instruments described herein are intended to be applicable to the additional embodiments of the methods, devices and instruments described herein except where expressly stated or where the feature or function is incompatible with the additional embodiments. For example, where a given feature or function is expressly described in connection with one embodiment but not expressly mentioned in connection with an alternative embodiment, it should be understood that the feature or function may be deployed, utilized, or implemented in connection with the alternative embodiment unless the feature or function is incompatible with the alternative embodiment.
[0025] The practice of some of the techniques described herein may employ, unless otherwise indicated, techniques and descriptions of molecular biology (includingrecombinant techniques), cell biology, biochemistry, and genetic engineering technology that may be known in the art, although certain combinations of these techniques are not known. Techniques and descriptions can be found in laboratory manuals such as Green and Sambrook, Molecular Cloning: A Laboratory Manual 4th Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (2014); Current Protocols in Molecular Biology, Ausubel, et al. eds., (2017); Neumann, et al., Electroporation and Electrofusion in Cell Biology, Plenum Press, New York (1989); Chang, et al., Guide to Electroporation and Electrofusion, Academic Press, California (1992); Kaplift and Loewy, eds., Viral Vectors, Academic Press (1995)); all of which are herein incorporated in their entirety by reference for all purposes. CRISPR editing techniques can be found in, e.g., Genome Editing and Engineering from TALENs and CRISPRs to Molecular Surgery, Appasani and Church (2018); and CRISPR: Methods and Protocols, Lindgren and Charpentier (2015); both of which are herein incorporated in their entirety by reference for all purposes.
[0026] Note that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a cell” refers to one or more cells, and reference to “the system” includes reference to equivalent steps, methods and devices known to those skilled in the art, and so forth. Additionally, it is to be understood that terms such as "left," "right," "top," "bottom," "front," "rear," "side," "height," "length," "width," "upper," "lower," "interior," "exterior," "inner," "outer" that may be used herein merely describe points of reference and do not necessarily limit embodiments of the present disclosure to any particular orientation or configuration. Lurthermore, terms such as "first," "second," "third," etc., merely identify one of a number of portions, components, steps, operations, functions, and / or points of reference as disclosed herein, and likewise do not necessarily limit embodiments of the present disclosure to any particular configuration or orientation.
[0027] The term “about”, “around” or “approximately”, when modifying the quantity (e.g., mg) of a substance or composition, or the value of a parameter characterizing a step in a method, or the like, refers to variation in the numerical quantity that can occur, for example, through typical measuring, handling, and sampling procedures involved in the preparation, characterization and / or use of the substance or composition; through an inadvertent error in these procedures; through differences in the manufacture, source, orpurity of the ingredients employed to make or use the compositions or carry out the procedures; and the like. In certain aspects, “about” can mean a variation of ± 0.1%, ± 0.5%, ± 1%, ± 2%, ± 3%, ± 4%, ± 5%, ± 6%, ± 7%, ± 8%, ± 9% or ± 10%.
[0028] To avoid any doubt, used herein, terms or phrases such as “about”, “at least”, “at least about”, “at most”, “less than”, “greater than”, “within” or “alike”, when followed by a series of list of numbers of percentages, such terms or phrases are deemed to modify each and every number of percentage in the series or list, regardless whether the adverb, preposition, or other modifier phrase is reproduced prior to each and every member.
[0029] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. All publications mentioned herein are incorporated by reference for the purpose of describing and disclosing devices, formulations and methodologies that may be used in connection with the presently described invention.
[0030] Where a range of values is provided, it is understood that each intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in smaller ranges, and are also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
[0031] In the following description, numerous specific details are set forth to provide a more thorough understanding of the present invention. However, it will be apparent to one of skill in the art that the present invention may be practiced without one or more of these specific details. In other instances, features and procedures well known to those skilled in the art have not been described in order to avoid obscuring the invention. The terms used herein are intended to have the plain and ordinary meaning as understood by those of ordinary skill in the art.
[0032] The term “barcode” herein refers to a nucleotide index or tag sequence, the presence of which may be utilized to indicate an editing event. A barcode can be any number of nucleotides in length.
[0033] The term "complementary" as used herein refers to Watson-Crick base pairing between nucleotides and specifically refers to nucleotides hydrogen bonded to one another with thymine or uracil residues linked to adenine residues by two hydrogen bonds and cytosine and guanine residues linked by three hydrogen bonds. In general, a nucleic acid includes a nucleotide sequence described as having a "percent complementarity" or “percent homology” to a specified second nucleotide sequence. For example, a nucleotide sequence may have 80%, 90%, or 100% complementarity to a specified second nucleotide sequence, indicating that 8 of 10, 9 of 10 or 10 of 10 nucleotides of a sequence are complementary to the specified second nucleotide sequence. For instance, the nucleotide sequence 3'-TCGA-5' is 100% complementary to the nucleotide sequence 5'-AGCT-3'; and the nucleotide sequence 3'-TCGA-5' is 100% complementary to a region of the nucleotide sequence 5'-TAGCTG-3'.
[0034] The term DNA "control sequences" refers collectively to promoter sequences, polyadenylation signals, transcription termination sequences, upstream regulatory domains, origins of replication, internal ribosome entry sites, nuclear localization sequences, enhancers, and the like, which collectively provide for the replication, transcription and translation of a coding sequence in a recipient cell. Not all of these types of control sequences need to be present so long as a selected coding sequence is capable of being replicated, transcribed and — for some components — translated in an appropriate host cell.
[0035] The terms “editing cassette”, “CREATE cassette”, “CREATE editing cassette”, “CREATE fusion editing cassette” or “CFE editing cassette” refer to — in the context of the present disclosure — a nucleic acid molecule comprising a coding sequence for transcription of a guide nucleic acid or gRNA covalently linked to a coding sequence — here, a large insert construct embedded in an insertion cassette — for transcription or reverse transcription of a repair template.
[0036] The terms “guide nucleic acid” or “guide RNA” or “gRNA” refer to a polynucleotide comprising 1) a guide sequence capable of hybridizing to a genomic target locus (i.e., a spacer sequences), and 2) a scaffold sequence capable of interacting or complexing with a nucleic acid-guided nuclease.
[0037] The term "heterologous" refers to the relationship between two or more nucleic acids or protein sequences from different sources, or the relationship between a protein (or nucleic acid) and a host cell from different sources. For example, if the combination of a nucleic acid and a host cell is usually not naturally occurring, the nucleic acid is heterologous to the host cell. A particular sequence is "heterologous" to the cell or organism into which it is inserted.
[0038] "Homology" or "identity" or "similarity" refers to sequence similarity between two peptides or, more often in the context of the present disclosure, between two nucleic acid molecules. The term "homologous region" or “homology arm” refers to a region on the repair template with a certain degree of homology with the target genomic DNA sequence. Homology can be determined by comparing a position in each sequence which may be aligned for purposes of comparison. When a position in the compared sequence is occupied by the same base or amino acid, then the molecules are homologous at that position. A degree of homology between sequences is a function of the number of matching or homologous positions shared by the sequences.
[0039] As used herein the terms “large inserts” or “large DNA insertions” or “large payloads” or “long stretches of DNA” or “large DNA payloads” refer to tracts of nucleic acids longer than > 100 bp, >200 bp, > Ikb, >5kb, >10 kb and up to 100 kb.
[0040] As used herein the terms “nucleic acid-guided nuclease”, “nuclease” or “CRISPR nuclease” refer to a nuclease that requires a guide nucleic acid, typically RNA, for target recognition and cleavage of DNA. As used herein, the term "nickase fusion" refers to a nucleic acid-guided nickase — or nucleic acid-guided nuclease or CRISPR nuclease that has been engineered to act as a nickase rather than a nuclease (i.e., the nickase portion of the fusion functions as a nickase as opposed to a nuclease that initiates doublestranded DNA breaks) — where the nickase is fused to a reverse transcriptase, which is an enzyme used to generate cDNA from an RNA template.
[0041] ‘Nucleic acid-guided editing components” refers to one, some, or all of a nucleic acid-guided nuclease or nickase fusion enzyme, a guide nucleic acid, and a repair template.
[0042] "Operably linked" refers to an arrangement of elements where the components so described are configured so as to perform their usual function. Thus, control sequencesoperably linked to a coding sequence are capable of initiating the transcription, and in some cases, the translation, of a coding sequence. The control sequences need not be contiguous with the coding sequence so long as they function to direct the expression of the coding sequence. Thus, for example, intervening untranslated yet transcribed sequences can be present between a promoter sequence and the coding sequence and the promoter sequence can still be considered "operably linked" to the coding sequence. In fact, such sequences need not reside on the same contiguous DNA molecule (i.e., chromosome) and may still have interactions resulting in altered regulation.
[0043] A “PAM mutation” refers to one or more edits to a target sequence that removes, mutates, or otherwise renders inactive a PAM or spacer region in the target sequence.
[0044] A “promoter” or “promoter sequence” is a DNA regulatory region capable of binding RNA polymerase and initiating transcription of a polynucleotide or polypeptide coding sequence such as messenger RNA, ribosomal RNA, small nuclear or nucleolar RNA, guide RNA, or any kind of RNA. Promoters may be constitutive or inducible.
[0045] As used herein, the terms "protein" and "polypeptide" are used interchangeably. Proteins may or may not be made up entirely of amino acids.
[0046] As used herein the terms "repair template" or “donor nucleic acid” or "donor DNA" refer to 1) nucleic acid that is designed to introduce a DNA sequence modification (insertion, deletion, substitution) into a locus by homologous recombination using nucleic acid-guided nucleases, or 2) a nucleic acid that serves as a template (including a desired edit) to be incorporated into target DNA by the reverse transcriptase portion of a nickase fusion in a CREATE fusion editing (CFE) system. For homology-directed repair, the repair template must have sufficient homology to the regions flanking the “cut site” or the site to be edited in the genomic target sequence. For template-directed repair, the repair template typically has homology to the genomic target sequence except at the position of the desired edit although synonymous edits may be present in the homologous (e.g., non-edit) regions. The length of the repair template(s) will depend on, e.g., the type and size of the modification being made and in the context of the present disclosure, the length of the repair template includes both the regions of homology to the target genomic sequence and the large insert construct, which is at least 100 bp in length or more. In many instancesand preferably, the repair template will have two regions of sequence homology (e.g., two homology arms) complementary to the genomic target locus flanking the locus of the desired edit in the genomic target locus. Typically, an "edit region” or “edit locus” or “DNA sequence modification” region — the nucleic acid modification that one desires to be introduced into a genome target locus in a cell (e.g., the desired edit) — will be located between two regions of homology.
[0047] As used herein the term “selectable marker” refers to a gene introduced into a cell, which confers a trait suitable for artificial selection. General use selectable markers are well-known to those of ordinary skill in the art. Drug selectable markers such as ampicillin / carbenicillin, kanamycin, chloramphenicol, nourseothricin N-acetyl transferase, erythromycin, tetracycline, gentamicin, bleomycin, streptomycin, puromycin, hygromycin, blasticidin, and G418 may be employed. In other embodiments, selectable markers include, but are not limited to human nerve growth factor receptor (detected with a MAb, such as described in USPN 6,365,373); truncated human growth factor receptor (detected with MAb); mutant human dihydrofolate reductase (DHFR; fluorescent MTX substrate available); secreted alkaline phosphatase (SEAP; fluorescent substrate available); human thymidylate synthase (TS; confers resistance to anti-cancer agent fluorodeoxyuridine); human glutathione S-transferase alpha (GSTA1; conjugates glutathione to the stem cell selective alkylator busulfan; chemoprotective selectable marker in CD34+cells); CD24 cell surface antigen in hematopoietic stem cells; human CAD gene to confer resistance to N- phosphonacetyl-L-aspartate (PALA); human multi-drug resistance- 1 (MDR-1; P- glycoprotein surface protein selectable by increased drug resistance or enriched by FACS); human CD25 (IL-2a; detectable by Mab-FITC); Methylguanine-DNA methyltransferase (MGMT; selectable by carmustine); rhamnose; and Cytidine deaminase (CD; selectable by Ara-C). “Selective medium” as used herein refers to cell growth medium to which has been added a chemical compound or biological moiety that selects for or against selectable markers.
[0048] The terms "target genomic DNA sequence", “target sequence”, or “genomic target locus” and the like refer to any locus in vitro or in vivo, or in a nucleic acid (e.g., genome or episome) of a cell or population of cells, in which an integration cassette — andultimately a large insert construct — is inserted. The target sequence can be a genomic locus or extrachromosomal locus.
[0049] The terms “transformation”, “transfection” and “transduction” are used interchangeably herein to refer to the process of introducing exogenous DNA into cells.
[0050] The term "variant" may refer to a polypeptide or polynucleotide that differs from a reference polypeptide or polynucleotide but retains essential properties. A typical variant of a polypeptide differs in amino acid sequence from another reference polypeptide. Generally, differences are limited so that the sequences of the reference polypeptide and the variant are closely similar overall and, in many regions, identical. A variant and reference polypeptide may differ in amino acid sequence by one or more modifications (e.g., substitutions, additions, and / or deletions). A variant of a polypeptide may be a conservatively modified variant. A substituted or inserted amino acid residue may or may not be one encoded by the genetic code (e.g., a non-natural amino acid). A variant of a polypeptide may be naturally occurring, such as an allelic variant, or it may be a variant that is not known to occur naturally.
[0051] A “vector” is any of a variety of nucleic acids that comprise a desired sequence or sequences to be delivered to and / or expressed in a cell. Vectors are typically composed of DNA, although RNA vectors are also available. Vectors include, but are not limited to, plasmids, fosmids, phagemids, virus genomes, BACs, YACs, PACs, synthetic chromosomes, and the like. In some embodiments, a coding sequence for a nucleic acid- guided nuclease is provided in a vector, referred to as an “engine vector.” In some embodiments, the editing cassette may be provided in a vector, referred to as an “editing vector.” In some embodiments, the coding sequence for the nucleic acid-guided nuclease and the editing cassette are provided in the same vector.Nuclease-Directed Genome Editing Generally
[0052] The compositions and methods described herein are employed to allow one to construct a library of editing vectors comprising large payloads / long stretches of DNA for performing nucleic acid nucl ease-directed genome editing (i.e., CRISPR editing) in a population of live cells in a massively parallel manner. Specifically, the compositions and methods presented herein facilitate editing nucleotide sequences in a population of cells ina multiplexed and targeted manner, including insertions of large DNA sequences (e.g., > 100 bp, >200 bp, > Ikb, >5kb, >10 kb and up to 100 kb, depending on the recipient cell type and choice of vector backbone) using a library of integration cassettes and a library of large insert constructs. In some embodiments, the large insert of interest is at least about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments, the large insert of interest is at most about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments, the large insert of interest is about 150 to about 250, about 200 to about 300, about 250 to about 350, about 300 to about 400, about 350 to about 450, about 400 to about 500, about 450 to about 550, about 500 to about 600, about 550 to about 650, about 600 to about 700, about 650 to about 750, about 700 to about 800, about 750 to about 850, about 800 to about 900, about 850 to about 950, about 900 to about 1000, about 950 to about 1050, about 1000 to about 1100, about 1050 to about 1150, about 1100 to about 1200, about 1150 to about 1250, about 1200 to about 1300, about 1250 to about 1350, about 1300 to about 1400, about 1350 to about 1450, about 1400 to about 1500, about 1450 to about 1550, about 1500 to about 1600, about 1550 to about 1650, about 1600 to about 1700, about 1650 to about 1750, about 1700 to about 1800, about 1750 to about 1850, about 1800 to about 1900, about 1850 to about 1950, about 1900 to about 2000, about 1950 to about 2050, about 2000 to about 2100, about 2050 to about 2150, about 2100 to about 2200, about 2150 to about 2250, about 2200 to about 2300, about 2250 to about 2350, about 2300 to about 2400, about 2350 to about 2450, about 2400 to about 2500, about 2450 to about 2550, about 2500 to about 2600, about 2550 to about 2650, about 2600 to about 2700, about 2650 to about 2750, about 2700 to about 2800, about 2750 to about 2850, about 2800 to about 2900, about 2850 to about 2950, about 2900 to about 3000, about 2950 to about 3050, about 3000 to about 3100, about 3050 to about 3150, about 3100 to about 3200, about 3150 to about 3250, about 3200 to about 3300, about 3250 to about 3350, about 3300 to about 3400, about 3350 to about 3450, about 3400 to about 3500, about 3450 to about 3550, about 3500 to about 3600, about 3550 to about 3650, about 3600 to about 3700, about 3650 to about 3750, about 3700 to about 3800, about 3750 to about 3850, about 3800 to about 3900, about 3850 to about 3950, about 3900 to about 4000, about 3950 to about 4050, about 4000 to about 4100, about 4050 to about 4150, about 4100 to about 4200, about 4150 to about4250, about 4200 to about 4300, about 4250 to about 4350, about 4300 to about 4400, about 4350 to about 4450, about 4400 to about 4500, about 4450 to about 4550, about 4500 to about 4600, about 4550 to about 4650, about 4600 to about 4700, about 4650 to about 4750, about 4700 to about 4800, about 4750 to about 4850, about 4800 to about 4900, about 4850 to about 4950, or about 4900 to about 5000 bp long. An advantage of the present methods and compositions is that they allow one to leverage molecular biology techniques to construct an editing library comprising several to many large insert constructs configured to integrate into several to many to 100 or more different loci in the genomes of cells in a population of cells in an efficient and cost-effective manner. The methods involve two rounds of cloning, with each round conducted in bulk or in “one pot”, resulting in a library of editing vectors.
[0053] In CRISPR editing generally, a nucleic acid-guided nuclease or nickase fusion complexed with an appropriate synthetic guide nucleic acid in a cell can cut the genome of the cell at a desired location. The guide nucleic acid helps the nucleic acid-guided nuclease or nickase fusion recognize and cut the DNA at a specific target sequence. By manipulating the nucleotide sequence of the guide nucleic acid, the nucleic acid-guided nuclease or nickase fusion may be programmed to target any DNA sequence for cleavage as long as an appropriate protospacer adjacent motif (PAM) is nearby. In certain aspects, the nucleic acid-guided nuclease or nickase fusion editing system may use two separate guide nucleic acid molecules that combine to function as a guide nucleic acid, e.g., a CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA). In other aspects and preferably, the guide nucleic acid is a single guide nucleic acid construct that includes both 1) a guide sequence capable of hybridizing to a genomic target locus, and 2) a scaffold sequence capable of interacting or complexing with a nucleic acid-guided nuclease or nickase fusion.
[0054] In general, a guide nucleic acid (e.g., gRNA) complexes with a compatible nucleic acid-guided nuclease or nickase fusion enzyme and can then hybridize with a target sequence, thereby directing the nuclease or nickase fusion to the target sequence. A guide nucleic acid can be DNA or RNA; alternatively, a guide nucleic acid may comprise both DNA and RNA. In some embodiments, a guide nucleic acid may comprise modified or non-naturally occurring nucleotides. Preferably and typically, the guide nucleic acid comprises RNA and the gRNA is encoded by a DNA sequence in an editing cassette alongwith the coding sequence for a repair template. Covalently linking the gRNA and repair template allows one to scale up the number of edits that can be made in a population of cells tremendously. In applications that do not involve large DNA payloads, the editing cassette comprising both the gRNA and the entirety of the repair template can be synthesized as a single oligonucleotide (see, e.g., USPNs 10,240,167; 10,266,849; 9,982,278; 10,351,877; 10,364,442; 10,435,715; 10,669,559; 10,711,284; 10,731,180). However, in the present methods and compositions, the gRNA and homology arms are contained within the integration cassette, where the desired edit resides within the large insert construct. The homology arms from the integration cassette and the large insert (desired edit) from the large insert construct together comprise the repair template.
[0055] The guide nucleic acid comprises a guide sequence, where the guide sequence is a polynucleotide sequence having sufficient complementarity with a target sequence to hybridize with the target sequence and direct sequence-specific binding of a complexed nucleic acid-guided nuclease or nickase fusion enzyme to the target sequence. The degree of complementarity between a guide sequence and the corresponding target sequence, when optimally aligned using a suitable alignment algorithm, is about or more than about 50%, 60%, 75%, 80%, 85%, 90%, 95%, 97.5%, 99%, or more. Optimal alignment may be determined with the use of any suitable algorithm for aligning sequences. In some embodiments, a guide sequence is about or more than about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 75, or more nucleotides in length. In some embodiments, a guide sequence is less than about 75, 50, 45, 40, 35, 30, 25, 20 nucleotides in length. Preferably the guide sequence is 10-30 or 15-20 nucleotides long, or 15, 16, 17, 18, 19, or 20 nucleotides in length.
[0056] In general, to generate an edit in a target sequence, the gRNA / nuclease or gRNA / nickase fusion complex binds to a target sequence as determined by the guide RNA, and the nuclease or nickase fusion recognizes a protospacer adjacent motif (PAM) sequence adjacent to the target sequence. The target sequence can be any polynucleotide endogenous or exogenous to the cell, or in vitro. A target sequence can be a sequence encoding a gene product (e.g., a protein) or a non-coding sequence (e.g., a regulatory polynucleotide, an intron, a PAM, a control sequence, or "junk" DNA). The proto-spacer mutation (PAM) is a short nucleotide sequence recognized by the gRNA / nucleasecomplex. The precise preferred PAM sequence and length requirements for different nucleic acid-guided nucleases or nickase fusions vary; however, PAMs typically are 2-7 base-pair sequences adjacent or in proximity to the target sequence and, depending on the nuclease or nickase, can be 5' or 3' to the target sequence.
[0057] In most embodiments, genome editing of a cellular target sequence both introduces a desired DNA change (i.e., the desired edit) to a cellular target sequence, e.g., the genomic DNA of a cell, and removes, mutates, or renders inactive a proto-spacer adjacent mutation (PAM) region or spacer in the cellular target sequence (e.g., thereby rendering the target site immune to further nuclease binding). Rendering the PAM and / or spacer at the cellular target sequence inactive precludes additional editing of the cell genome at that cellular target sequence, e.g., upon subsequent exposure to a nucleic acid- guided nuclease or nickase fusion complexed with a synthetic guide nucleic acid in later rounds of editing. Thus, cells having the desired cellular target sequence edit and an altered PAM or spacer can be selected for by using a nucleic acid-guided nuclease or nickase fusion complexed with a synthetic guide nucleic acid complementary to the cellular target sequence. Cells that did not undergo the first editing event will be cut rendering a doublestranded DNA break, and thus will not continue to be viable. The cells containing the desired cellular target sequence edit and PAM or spacer alteration will not be cut, as these edited cells no longer contain the necessary PAM site and will continue to grow and propagate.
[0058] As for the nuclease or nickase fusion component of the nucleic acid-guided nuclease editing system, a polynucleotide sequence encoding the nucleic acid-guided nuclease or nickase fusion can be codon-optimized for expression in particular cell types, such as bacterial, yeast, and, here, mammalian cells. The choice of the nucleic acid-guided nuclease or nickase fusion to be employed depends on many factors, such as what type of edit is to be made in the target sequence and whether an appropriate PAM is located close to the desired target sequence. Nucleases of use in the methods described herein include but are not limited to Cas 9, Cas 12, MAD2, or MAD7, MAD 2007 or other MADzymes and MADzyme systems (see USPNs 10,604,746; 10,655,114; 10,649,754; 10,876,102; 10,833,077; 11,053,485; 10,704,022; 10,745,678; 10,724,021; 10,767,169; 10,870,761; 10,011,849; 10,435,714; 10,626,416; 9,982,279; and 10,337,028; and USSNs 16 / 953,253;17 / 374,628; 17,200,074; 17,200,089; 17 / 200,110; 16 / 953,233; 17 / 463,498; 63 / 134,938; 16 / 819,896; 17 / 179,193; and 16 / 421,783 for sequences and other details related to engineered and naturally-occuring MADzymes). Nickase fusion enzymes typically comprise a CRISPR nucleic acid-guided nuclease engineered to cut one DNA strand in the target DNA rather than making a double-stranded cut, and the nickase portion is fused to a reverse transcriptase. In specific aspects, the one or more nickases include MAD7 nickase, MAD2001 nickase, MAD2007 nickase, MAD2008 nickase, MAD2009 nickase, MAD2011 nickase, MAD2017 nickase, MAD2019 nickase, MAD297 nickase, MAD298 nickase, MAD299 nickase, or other MAD-series nickases, variants thereof, and / or combinations thereof as described in USPN 10,883,077; 11,053,485; 11,085,030; 11,200,089; 11,193,115; and USSN 17 / 463,498. A coding sequence for a desired nuclease or nickase fusion may be on an "engine vector" along with other desired sequences such as a selective marker(s), or a coding sequence for the desired nuclease or nickase may reside on the editing vector (i.e., the vector backbone into which the integration cassette is inserted, then the integration cassette into which the large insert construct is then inserted) or may be transfected into a cell as a protein.
[0059] Another component of the nucleic acid-guided nuclease or nickase fusion system is the repair template comprising homology to the cellular target sequence. The repair template typically is designed to serve as a template for homologous recombination with a cellular target sequence cleaved by the nucleic acid-guided nuclease or the repair template serves as the template for template-directed repair via the nickase fusion, as a part of the gRNA / nuclease complex. In the present methods and compositions, the gRNA and homology arms are contained within the integration cassette, where the desired edit resides within the large insert construct. The homology arms from the integration cassette and the large insert (desired edit) from the large insert construct together comprise the repair template, whether the repair template is designed for homologous recombination or for template-directed repair.
[0060] In addition and as described in detail herein, the integration cassettes, vector backbone and / or large insert constructs comprise one or more primer binding sites to, e.g., allow for PCR amplification, to linearize the integration vector, and to interrogate the regions of integration into the cellular genome and / or to ascertain the precise sequence ofthe large payload. The primer binding sites are used to amplify the editing cassette by using oligonucleotide primers as described infra (see, e.g., FIG. IE), and may be biotinylated or otherwise labeled. In addition, the large inert construct may comprise a barcode or amplification primers used to amplify the large insert constructs. A barcode is a unique DNA sequence that corresponds to the repair template sequence such that the barcode serves as a proxy to identify the edit made to the corresponding cellular target sequence. The barcode typically comprises four or more nucleotides. Also, in some embodiments the editing vector further comprises one or more nuclear localization sequences (NLSs), such as about or more than about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more NLSs.Construction of Integration Cassettes, Integration Vector Libraries, Large Insert Constructs and Editing Vectors
[0061] The compositions and methods described herein are employed to allow one to construct a library of editing vectors comprising large inserts / long stretches of DNA for performing nucleic acid nucl ease-directed genome editing (i.e., CRISPR editing) in a population of live cells in a massively parallel manner. Specifically, the compositions and methods presented herein facilitate editing nucleotide sequences in a population of cells in a multiplexed and targeted manner, including insertions of large DNA sequences (e.g., > 100 bp, >200 bp, > Ikb, >5kb, >10 kb and up to 100 kb, depending on the recipient cell type and choice of vector backbone) using a library of integration cassettes and a library of large insert constructs. In some embodiments, the large insert of interest is at least about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments, the large insert of interest is at most about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long. In some embodiments, the large insert of interest is about 150 to about 250, about 200 to about 300, about 250 to about 350, about 300 to about 400, about 350 to about 450, about 400 to about 500, about 450 to about 550, about 500 to about 600, about 550 to about 650, about 600 to about 700, about 650 to about 750, about 700 to about 800, about 750 to about 850, about 800 to about 900, about 850 to about 950, about 900 to about 1000, about 950 to about 1050, about 1000 to about 1100, about 1050 to about 1150, about 1100 to about 1200, about 1150 to about1250, about 1200 to about 1300, about 1250 to about 1350, about 1300 to about 1400, about 1350 to about 1450, about 1400 to about 1500, about 1450 to about 1550, about 1500 to about 1600, about 1550 to about 1650, about 1600 to about 1700, about 1650 to about 1750, about 1700 to about 1800, about 1750 to about 1850, about 1800 to about 1900, about 1850 to about 1950, about 1900 to about 2000, about 1950 to about 2050, about 2000 to about 2100, about 2050 to about 2150, about 2100 to about 2200, about 2150 to about 2250, about 2200 to about 2300, about 2250 to about 2350, about 2300 to about 2400, about 2350 to about 2450, about 2400 to about 2500, about 2450 to about 2550, about 2500 to about 2600, about 2550 to about 2650, about 2600 to about 2700, about 2650 to about 2750, about 2700 to about 2800, about 2750 to about 2850, about 2800 to about 2900, about 2850 to about 2950, about 2900 to about 3000, about 2950 to about 3050, about 3000 to about 3100, about 3050 to about 3150, about 3100 to about 3200, about 3150 to about 3250, about 3200 to about 3300, about 3250 to about 3350, about 3300 to about 3400, about 3350 to about 3450, about 3400 to about 3500, about 3450 to about 3550, about 3500 to about 3600, about 3550 to about 3650, about 3600 to about 3700, about 3650 to about 3750, about 3700 to about 3800, about 3750 to about 3850, about 3800 to about 3900, about 3850 to about 3950, about 3900 to about 4000, about 3950 to about 4050, about 4000 to about 4100, about 4050 to about 4150, about 4100 to about 4200, about 4150 to about 4250, about 4200 to about 4300, about 4250 to about 4350, about 4300 to about 4400, about 4350 to about 4450, about 4400 to about 4500, about 4450 to about 4550, about 4500 to about 4600, about 4550 to about 4650, about 4600 to about 4700, about 4650 to about 4750, about 4700 to about 4800, about 4750 to about 4850, about 4800 to about 4900, about 4850 to about 4950, or about 4900 to about 5000 bp long. An advantage of the present methods and compositions is that they allow one to leverage molecular biology techniques to construct an editing library comprising several to many large insert constructs configured to integrate into several to many different loci in the genomes of cells in a population of cells in an efficient and cost-effective manner.
[0062] In some aspects, the present disclosure further provides a method for performing nucleic acid nucl ease-directed genome editing (i.e., CRISPR editing) in a population of live cells in a massively parallel manner using the library of editing vectors disclosed herein.
[0063] FIG. 1 is a simple process diagram for performing a method 100 of multiplexed nucleic acid-guided nuclease editing using large DNA payloads in a population of cells. In a first step, a library of integration cassettes comprising primer handles is designed and synthesized 101. As described in more detail below, the integration cassettes comprise 1) a gRNA comprising a scaffold region capable of interacting or complexing with a nucleic acid-guided nuclease and a guide sequence capable of hybridizing to a genomic target locus of interest; and 2) two portions of a donor DNA, comprising from 5' to 3': a first region of homology to the target locus of interest, a first “primer handle”, a second “primer handle”, and a second region of homology to the target locus of interest. In addition, primer sites typically flank the integration cassette at the 5' and 3' ends of the integration cassette to facilitate amplification of the cassettes. The integration cassettes are designed to target different loci in the cellular genome; that is, the integration cassettes are designed to insert desired large DNA payloads into different loci in the genome in a population of cells — typically and preferably at one locus per cell. The integration cassette is essentially a modified CREATE cassette (i.e., editing cassette) comprising a gRNA covalently linked to a repair template or donor DNA; however in the present methods, the donor DNA comprises two regions of homology to the cellular genome and two primer handles from the integration cassette with the desired edit to be made supplied by the large insert construct as described in more detail infra. Methods and compositions for designing and synthesizing editing cassettes (e.g., CREATE cassettes) are described in USPNs 10,240,167; 10,266,849; 9,982,278; 10,351,877; 10,364,442; 10,435,715; 10,465,207; 10,669,559; 10,771,284; 10,731,180; and 11,078,498.
[0064] The integration cassettes may be 200 bp or less in length and as such can be synthesized by oligonucleotide synthesis methods known in the art. For example, the vast majority of oligonucleotides are synthesized on automated synthesizers using phosphoramidite methodology. Phosphoramidite methodology is based on the use of DNA phosphoramidite nucleosides that are modified with a 4, 4' -dimethoxy trityl (DMTr) protecting group on the 5'-OH, a B-cyanoethyl -protected 3'-phosphite and appropriate conventional protecting groups on the reactive primary amines in the heterocyclic nucleobase. The four classic protected DNA nucleoside phosphoramidites are benzoyl- dA, benzoyl-dC, iso-butyryl-dG and dT (which requires no base protection). Additionally,both acetyl-dC and dimethylformamidine-dG are now also routinely used. The phosphoramidite approach is carried out almost exclusively on automated synthesizers using controlled-pore glass or polystyrene solid supports. (For a review, see Caruthers, Biochem. Soc. Trans., 39:575-80 (2011).) In some synthesis schemes, supports are held in small synthesis ‘columns’ that act as a reaction vessel; however, in the present methods, the integration cassettes are typically synthesized on a solid support where the integration cassettes are de-coupled from the support and amplified.
[0065] If the integration cassettes exceed in size the capabilities of automated oligonucleotide synthesis (i.e., >200 bp), assembly of large integration cassettes can be assembled from shorter oligonucleotides comprising components of the integration cassettes by use of, e.g., supplemental oligonucleotides. Currently there are dozens of different methods using various types of PCR to assemble long single-stranded oligonucleotides. A summary of many of these methods is reviewed by Xiong, et al., FEMS Microbiol. Rev., 32:522-40 (2008) and Ma, et al., Curr. Op. Chem Biol. 16:260-67 (2012). Generally, these methods use the supplemental oligonucleotides with complementary overlapping sequences to the shorter oligonucleotides comprising components of the integration cassettes to assemble the full l ength editing constructs using a thermostable polymerase and PCR, where the only differences between the myriad of PCR-based DNA assembly methods is in how the substituent oligonucleotides are designed to be assembled together and the reaction conditions under which they are assembled. These methods allow assembly of short oligonucleotides to make oligonucleotides from 250 to 2000 bp in length.
[0066] Once the integration cassetes are synthesized 101, the library of integration cassettes is amplified 102; e.g., using the primer amplification sites in the integration cassettes as described above. Following amplification, the library of integration cassettes is inserted into a vector backbone to create an integration vector library 103. A number of methods may be used to assemble the integration vectors including Gibson Assembly®, CPEC, SLIC, Ligase Cycling, etc. Additional assembly methods include gap repair in yeast (Bessa, Yeast, 29(10):419-23 (2012)); gateway cloning (Ohtsuka, Current Pharm. Biotechnology, 10(2):244-51 (2009), USPN 5,888,732 to Hartley, et al; USPN 6,277,608 to Hartley, et al.); and topoisomerase-mediated cloning (Udo, PLoS One,T110(9): eOl 39349 (2015); USPN 6,916,632 to Chestnut, et al.). These and other nucleic acid assembly techniques are described, e.g., in Sands and Brent, Current Protocols in Molecular Biology, 113:3.26.1-3.26.20 (2016); Casini, et al., Nature Reviews of Molecular Cell Biology, (9): 568-76 (2015); Patron, Current Opinion Plant Biology, 19: 14- 9 (2014).
[0067] Once the library of integration vectors is created 103, each integration vector in the library of integration vectors is linearized 104 using the primer handles in the integration cassette that are positioned at the 3' end of the first region of homology to the target locus of interest and at the 5' end of the second region of homology to the target locus of interest (described and illustrated in more detail in relation to FIGs. 2C and 2D) and performing inverse PCR. Inverse PCR is a variant of the polymerase chain reaction that is used to amplify DNA with only one known sequence. In the present case, all the sequences in the integration vector library are known; however, inverse PCR is employed to convert the circular integration vectors in the library to linear integration vectors, where the first region of homology to the target locus and the primer handle adjacent this first region are at one end of the linear integration vector, and the second region of homology to the target locus and the primer handle adjacent to this second region are at the other end of the linear integration vector.
[0068] The vector backbone may be derived from plasmids, fosmids, phagemids, virus genomes, BACs, YACs, PACs, or synthetic chromosomes, and may comprise antibiotic selection sequences, one or more origins of replication, elements for inducible transcription of various genetic elements, control sequences, a coding sequence for the nucleic acid- guided nuclease or nickase fusion to be used in cell editing, or other desired sequences. Additionally, the vector backbone may comprise a promoter positioned 5' of the integration cassette for driving transcription of the gRNA scaffold and guide sequence, as well as the donor DNA comprising the first and second regions of homology from the integration cassette and the large insert construct; alternatively, the promoter driving transcription of these elements may reside in the integration cassette itself 5' of the gRNA scaffold.
[0069] In parallel with the design, synthesis and amplification of the integration cassettes and construction and linearization of the integration vectors, a library of large insert constructs of interest are designed and synthesized 105. The large inserts or payloadsmay comprise promoters (e.g., a library of promoters, including eukaryotic promoters), other control sequences, entire genes, and more than one gene including some or all genes involved in one or more biochemical pathways. In addition, the large insert constructs comprise regions of homology to the integration cassettes and the large insert constructs most often include one or more edits to the PAM (protospacer adjacent motif) or spacer. As with the synthesis of the integration cassettes described above, the large insert constructs may be synthesized by oligonucleotide synthesis, including assemblies of oligonucleotides to build the large insert constructs. Alternatively, large inserts can be prepared by cloning and amplification of desired sequences from existing genomic DNA samples. As with the integration cassettes, there may be and typically are additional elements within the large insert constructs, such as primer sequences that facilitate amplification of the large insert constructs. Once the library of large insert constructs are designed and synthesized 105, the large insert constructs in the library of large insert constructs are amplified 106 using primers homologous to the primer sequences in the large insert constructs. In some embodiments, the primers used to amplify the large insert constructs comprise barcodes, including primers comprising degenerate barcodes.
[0070] In step 107, a library of editing vectors is assembled from the linear integration vectors and the large insert constructs. Assembly of these elements may be accomplished by any number of methods as described above including Gibson Assembly®, CPEC, SLIC, or Ligase Cycling as described supra in relation to assembly of the integration cassettes and the vector backbone.
[0071] Once the library of editing vectors has been assembled, the editing vectors may be transformed or transfected into cells for editing 108. Cells include any prokaryotic, archaeal or eukaryotic cell. For example, prokaryotic cells for use with the present illustrative embodiments can be gram positive bacterial cells, e.g., Bacillus subtilis, or gram-negative bacterial cells, e.g., E. coli cells. Eukaryotic cells for use with the automated multi-module cell editing instruments of the illustrative embodiments include any plant cells and any animal cells, e.g., fungal cells, insect cells, amphibian cells, nematode cells, or mammalian cells. In some embodiments, eukaryotic cells for use with the present illustrative embodiments can be yeast cells, e.g., Saccharomyces cerevisiae (S. cerevisiae), Yarrowia lipolytica, Pichia pastoris, or Kluyveromyces marxianus cells.
[0072] A variety of art-recognized techniques for introducing an exogenous nucleic acid sequence (e.g., DNA) into a target cell, and the term “transformation” as used herein includes all transformation and transfection techniques. Such methods include, but are not limited to, electroporation, lipof ection, optoporation, injection, microprecipitation, microinjection, liposomes, particle bombardment, sonoporation, laser- induced poration, bead transfection, calcium phosphate or calcium chloride co-precipitation, or DEAE- dextran-mediated transfection. Cells can also be prepared for vector uptake using, e.g., a sucrose or glycerol wash. Additionally, hybrid techniques that exploit the capabilities of mechanical and chemical transfection methods can be used, e.g., magnetot 'ection, a transfection methodology that combines chemical transfection with mechanical methods. In another example, cationic lipids may be deployed in combination with gene guns or electroporators. Suitable materials and methods for transforming or transfecting target cells can be found, e.g., in Green and Sambrook, Molecular Cloning: A Laboratory Manual, 4th, Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 2014).
[0073] Once transformed, conditions are provided to facilitate nucleic acid-guided nuclease or nickase fusion cell editing. Conditions may include providing appropriate cell growth medium and / or inducing transcription of one or more of the nucleic acid-guided (or nickase fusion) editing components. A number of gene regulation control systems have been developed for the controlled expression of genes in plant, microbe, and animal cells, including mammalian cells, including, in addition to the pL promoter, the pPhlF promoter (induced by the addition of 2,4 diacetylphloroglucinol (DAPG)), the pBAD promoter (induced by the addition of arabinose to the cell growth medium), and the rhamnose inducible promoter (induced by the addition of rhamnose to the cell growth medium). Other systems include the tetracycline-controlled transcriptional activation system (Tet- On / Tet-Off, Clontech, Inc. (Palo Alto, CA); Bujard and Gossen, PNAS, 89(12): 5547-5551 (1992)), the Lac Switch Inducible system (Wyborski, et al., Environ Mol Mutagen, 28(4):447-58 (1996); DuCoeur, et al., Strategies 5(3):70-72 (1992); USPN 4,833,080), the ecdysone-inducible gene expression system (No, et al., PNAS, 93(8):3346-3351 (1996)), the cumate gene-switch system (Mullick, et al., BMC Biotechnology, 6:43 (2006)), and the tamoxifen-inducible gene expression (Zhang, et al., Nucleic Acids Research, 24:543-548 (1996)) as well as others.
[0074] In a last step, the cells are analyzed 109 by various phenotypic assays.
[0075] FIG. 2A is a simplified representation of a library 135 of three different integration cassettes 110, 120 and 130. Integration cassette 110 of integration cassette library 135 comprises a first site of homology to the vector backbone 118; a gRNA scaffold region capable of interacting or complexing with a nucleic acid-guided nuclease or nickase fusion 111 ; a guide sequence capable of hybridizing to a first genomic target locus of interest 112 (in this case, a first genomic target region for insertion of a large insert construct); a first region of homology to the first target locus of interest 113 (i.e., the first genomic target region for insertion of a large insert construct); a first primer handle 116; a second primer handle 117; a second region of homology to the first target locus of interest 114 (i.e., the first genomic target region for insertion of a large insert construct); and a second site of homology to the vector backbone 115.
[0076] Integration cassette 120 of integration cassette library 135 comprises a first site of homology to the vector backbone 118; a gRNA scaffold region capable of interacting or complexing with a nucleic acid-guided nuclease or nickase fusion 111 ; a guide sequence capable of hybridizing to a second genomic target locus of interest 122 (in this case, a second genomic target region for insertion of a large insert construct); a first region of homology to the second target locus of interest 123 (i.e., the second genomic target region for insertion of a large insert construct); a first primer handle 116; a second primer handle 117; and a second region of homology to the second target locus of interest 124 (i.e., the second genomic target region for insertion of a large insert construct); and a second site of homology to the vector backbone 115.
[0077] Integration cassette 130 of integration cassette library 135 comprises a first site of homology to the vector backbone 118; a gRNA scaffold region capable of interacting or complexing with a nucleic acid-guided nuclease or nickase fusion 111 ; a guide sequence capable of hybridizing to a third genomic target locus of interest 132 (in this case, a third genomic target region for insertion of a large insert construct); a first region of homology to the third target locus of interest 133 (i.e., the third genomic target region for insertion of a large insert construct); a first primer handle 116; a second primer handle 117; and a second region of homology to the third target locus of interest 134 (i.e., the third genomictarget region for insertion of a large insert construct); and a second site of homology to the vector backbone 115.
[0078] In the present methods, the first site of homology to the vector backbone is approximately 100-1000 bp in length; the gRNA scaffold region is approximately 20-40 bp in length; the guide region of the gRNA is approximately 10-20 bp in length; the first region of homology to the target locus is approximately 100- 1000 bp in length; the first and second primer handles are each approximately 20-30 bp in length; the second region of homology to the target locus is approximately 100-1000 bp in length; and the second site of homology to the vector backbone is approximately 100-1000 bp in length. Thus, the size of the integration cassette ranges from approximately 450-4100 bp in length. The length of the guide sequence and the regions of homology in different integration cassettes may be different or may be the same. Typically, the size of the library of integration cassettes will range from 1-100 integration cassettes, depending on cell type, the number of loci chosen for integration, the size of the large insert constructs and the size of the vector backbone.
[0079] FIG. 2B is a simplified representation of a method of inserting one of the integration cassettes into a vector backbone. FIG. 2B illustrates a vector backbone 140 having a homology region 118' which, together with the first site of homology 118 in insertion cassette 110, and homology region 115' which, together with the second site of homology 115 in insertion cassette 110, facilitates insertion of integration cassette 110 into vector backbone 140 via, e.g., Gibson Assembly®. In addition to homology regions 118' and 115' in vector backbone 140, the following regions of integration cassettes 110 can be seen: gRNA scaffold region capable of interacting or complexing with a nucleic acid- guided nuclease or nickase fusion 111; guide sequence capable of hybridizing to a first genomic target locus of interest 112; first region of homology to the first target locus of interest 113; first primer handle 116; second primer handle 117; and second region of homology to the first target locus of interest 114. Note that regions 118 and 115 are common to all integration cassettes allowing for insertion of the integration cassettes (110, 120, and 130) into any one of the vector backbones. As described previously, the vector backbone may be a plasmid, fosmid, phagemid, virual vector and typically comprises sequences such as the coding sequence for the nucleic acid-guided nuclease or nickasefusion, selection sequences, and origins of replication. In addition, the vector backbone may further include components of the lambda (X) Red recombineering system. The A. Red recombineering system works as a “band aid” or repair system for double-strand breaks in bacteria such as those induced by nucleic acid-guided nucleases, and in some species of bacteria the X Red recombineering system (or some other recombineering system) must be present for the double-strand breaks that occur during editing to resolve. However, in other microbes and in eukaryotic cells, recombineering systems are not required.
[0080] FIG. 2C is a simplified representation of an integration cassette having been inserted into a vector backbone to create an integration vector 142. Seen are assembled site 118" (formed by the assembly of region 118 from the integration cassette 110 and region 118' from vector backbone 140); gRNA scaffold region 111; guide sequence 112; first region of homology to the first target locus of interest 113; first primer handle 116; second primer handle 117; second region of homology to the first target locus of interest 114; and assembled site 115" (formed by the assembly of region 115 from the integration cassette 110 and region 115' from vector backbone 140).
[0081] FIG. 2D is a simplified representation of the integration vector of FIG. 2C that has been linearized by, e.g., inverse PCR, which uses single primers homologous to the first primer handle 116 and second primer handle 117 to create linearized copies 144 of integration vector 142 (not shown in this FIG. 2D, but see FIG. 2C). As above in FIG. 2C, seen are assembled site 118" (formed by the assembly of region 118 from the integration cassette 110 and region 118' from vector backbone 140); gRNA scaffold region 111; guide sequence 112; first region of homology to the first target locus of interest 113; first primer handle 116; second primer handle 117; second region of homology to the first target locus of interest 114; and assembled site 115" (formed by the assembly of region 115 from the integration cassette 110 and region 115' from vector backbone 140).
[0082] FIG. 2E is a simplified representation of a library 150 of large insert constructs 171, 172, 173, 174, and 175. A first large insert construct 171 comprises a first site of homology to integration vector 116'; a first large insert or payload 151; an optional first barcode 161; and a second site of homology to integration vector 117'. A second large insert construct 172 comprises first site of homology to integration vector 116'; a second large insert or payload 152; an optional second barcode 162; and second site of homologyto integration vector 117'. A third large insert construct 173 comprises first site of homology to integration vector 116'; a third large insert or payload 153; an optional third barcode 163; and second site of homology to integration vector 117'. A fourth large insert construct 174 comprises first site of homology to integration vector 116'; a fourth large insert or payload 154; an optional fourth barcode 164; and second site of homology to integration vector 117'. A fifth large insert construct 175 comprises first site of homology to integration vector 116'; a fifth large insert or payload 155; an optional fifth barcode 165; and second site of homology to integration vector 117'. Note that the first site of homology to integration vector 116' and the second site of homology to integration vector 117' are common to all large insert constructs allowing for insertion into any one of the large insert constructs into the library of integration vectors.
[0083] FIG. 2F is a simplified representation of inserting one of the large insert constructs 171 from FIG. 2E into the linearized integration vector 144 of FIG. 2D. FIG. 2F illustrates a vector backbone 144 having a homology region 116 (originating in the integration cassette) which, together with the first site of homology 116' in large insert construct 171 and homology region 117' which, together with the second site of homology 117 in large insert construct 171, facilitates insertion of large insert construct 171 into linearized vector backbone 144 via, e.g., Gibson Assembly®. In this FIG. 2F, the following regions can be seen: assembled site 118" in linearized backbone 144; gRNA scaffold region 111 in linearized backbone 144; guide sequence 112 in linearized backbone 144; first region of homology to the first target locus of interest 113 in linearized backbone 144; first primer handle 116 in linearized backbone 144; first site of homology 116' in large insert construct 171; first large insert 151 in large insert construct 171; optional first barcode 161 in large insert construct 171; second site of homology to integration vector 117' in large insert construct 171; second primer handle 117 in linearized backbone 144; second region of homology to the first target locus of interest 114 in linearized backbone 144; and assembled site 115" in linearized backbone 144.
[0084] FIG. 2G is a simplified representation of one editing vector (from a library of editing vectors) created via the methods described herein and shown in FIGs. 2A - 2F. Seen are assembled site 118"; gRNA scaffold region 111; guide sequence 112; first region of homology to the first target locus of interest 113; left synthetic landing pad used asoverlap region in second round of Gibson assembly 116'); first large insert 151 ; an optional first barcode 161; right synthetic landing pad used as overlap region in second round of Gibson assembly 117 and first site of homology 117'); second region of homology to the first target locus of interest 114; and assembled site 115" in circularized backbone 143,
[0085] FIG. 2H is a simplified representation of the large insert construct integrated into a locus in a cellular genome showing positions of primers that may be used to interrogate the insertion sites and the large insert construct. Seen in this FIG. 2H is the integration cassette and large insert construct from FIG. 2G imbedded in a genomic site 165. PCR primers 1 (“PCR1”) interrogate the 5' site of integration into the genome; PCR primers 2 (“PCR2”) interrogate the 3' site of integration into the genome; and PCR primers 3 (“PCR3”) interrogate the barcode 161 (not labeled in this FIG. 2H but see FIG. 2G) and the large insert construct.EXAMPLES
[0086] The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the present invention and are not intended to limit the scope of what the inventors regard as their invention, nor are they intended to represent or imply that the experiments below are all of or the only experiments performed. It will be appreciated by persons skilled in the art that numerous variations and / or modifications may be made to the invention as shown in the specific aspects without departing from the spirit or scope of the invention as broadly described. The present aspects are, therefore, to be considered in all respects as illustrative and not restrictive.Example 1: Editins Cassette and Backbone Amplification and Assembly
[0087] Editing Cassette Preparation: 5 nM of oligonucleotides synthesized on a chip were amplified using Q5 polymerase in 50 pL volumes. The PCR conditions were 95°C for 1 minute; 8 rounds of 95°C for 30 seconds / 60°C for 30 seconds / 72°C for 2.5 minutes; with a final hold at 72°C for 5 minutes. Following amplification, the PCR products were subjected to SPRI cleanup, where 30pL SPRI mix was added to the 50 pL PCR reactions and incubated for 2 minutes. The tubes were subjected to a magnetic field for 2 minutes,the liquid was removed, and the beads were washed 2x with 80% ethanol, allowing 1 minute between washes. After the final wash, the beads were allowed to dry for 2 minutes, 50 pL 0.5x TE pH 8.0 was added to the tubes, and the beads were vortexed to mix. The slurry was incubated at room temperature for 2 minutes, then subjected to the magnetic field for 2 minutes. The eluate was removed and the DNA quantified.
[0088] Following quantification, a second amplification procedure was carried out using a dilution of the eluate from the SPRI cleanup. PCR was performed under the following conditions: 95°C for 1 minute; 18 rounds of 95°C for 30 seconds / 72°C for 2.5 minutes; with a final hold at 72°C for 5 minutes. Amplicons were checked on a 2% agarose gel and pools with the cleanest output(s) were identified. Amplification products appearing to have heterodimers or chimeras were not used.
[0089] Backbone Preparation: A 10-fold serial dilution series of purified backbone was performed, and each of the diluted backbone series was amplified under the following conditions: 95°C for 1 minute; then 30 rounds of 95°C for 30 seconds / 60°C for 1.5 minutes / 72°C for 2.5 minutes; with a final hold at 72°C for 5 minutes. After amplification, the amplified backbone was subjected to SPRI cleanup as described above in relation to the cassettes. The backbone was eluted into 100 pL ddH2O and quantified before isothermal assembly.
[0090] Gibson Assembly: 150 ng backbone DNA was combined with 100 ng cassette DNA. An equal volume of 2x Gibson Master Mix was added, and the reaction was incubated for 45 minutes at 50°C. After assembly, the assembled backbone and cassettes were subjected to SPRI cleanup, as described above.EXAMPLE 3: Transformation of Yeast
[0091] Electrocompetent yeast cells were transformed with a cloned library, an isothermal assembled library, or a process control sgRNA plasmid (escapee surrogate). Electrocompetent Saccharomyces cerevisiae cells were prepared as follows: The afternoon before transformation was to occur, 10 mL of YPAD was inoculated with the selected Saccharomyces cerevisiae strain. The culture was shaken at 250 RPM and 30°C overnight. The next day, 100 mL of YPAD was added to a 250-mL baffled flask and inoculated with the overnight culture (around 2 mL of overnight culture) until the OD600 reading reached0.3 + / - 0.05. The culture was placed in the 30°C incubator shaking at 250 RPM and allowed to grow for 4-5 hours, with the OD checked every hour. When the culture reached an OD600 of approximately 1.5, 50 mL volumes were poured into two 50-mL conical vials, then centrifuged at 4300 RPM for 2 minutes at room temperature. The supernatant was removed from all 50ml conical tubes, while avoiding disturbing the cell pellet. 50 mL of a Lithium Acetate / Dithiothreitol solution was added to each conical tube and the pellet was gently resuspended. Both suspensions were transferred to a 250 mL flask and placed in the shaker; then shaken at 30 °C and 200 RPM for 30 minutes.
[0092] After incubation was complete, the suspension was transferred to two 50-mL conical vials. The suspensions then were centrifuge at 4300 RPM for 3 minutes, then the supernatant was discarded. Following the lithium acetate / Dithiothreitol treatment step, cold liquids were used and the cells were kept on ice until electroporation. 50 mL of 1 M sorbitol was added and the pellet was resuspended, then centrifuged at 4300 RPM, 3 minutes, 4 °C, after which the supernatant was discarded. The IM sorbitol wash was repeated twice for a total of three washes. 50 uL of 1 M sorbitol was added to one pellet, cells were resuspended, then transferred to the other tube to suspend the second pellet. The volume of the cell suspension was measured and brought to 1 mL with cold 1 M sorbitol. At this point the cells were electrocompetent and could be transformed with a cloned library, an isothermal assembled library, or process control sgRNA plasmids.
[0093] In brief, a required number of 2 -mm gap electroporation cuvettes were prepared by labeling the cuvettes and then chilling on ice. The appropriate plasmid — or DNA mixture — was added to each corresponding cuvette and placed back on ice. 100 uL of electrocompetent cells was transferred to each labelled cuvette, and each sample was electroporated using appropriate electroporator conditions. 900 uL of room temperature YPAD Sorbitol media was then added to each cuvette. The cell suspension was transferred to a 14 ml culture tube and then shaken at 30 °C, 250 RPM for 3 hours. After a 3 hr recovery, 9 ml of YPAD containing the appropriate antibiotic, e.g., geneticin or Hygromycin B, was added. After the 3 -hour recovery in YPAD the transformed cells were diluted and a 3 ml volume of the diluted cells were plated.OTHER EMBODIMENTS
[0094] While this invention is satisfied by embodiments in many different forms, as described in detail in connection with preferred embodiments of the invention, it is understood that the present disclosure is to be considered as exemplary of the principles of the invention and is not intended to limit the invention to the specific embodiments illustrated and described herein. Numerous variations may be made by persons skilled in the art without departure from the spirit of the invention. The scope of the invention will be measured by the appended claims and their equivalents. The abstract and the title are not to be construed as limiting the scope of the present invention, as their purpose is to enable the appropriate authorities, as well as the general public, to quickly determine the general nature of the invention. In the claims that follow, unless the term “means” is used, none of the features or elements recited therein should be construed as means-plus-function limitations pursuant to 35 U.S.C., section 112, ^[6.
Claims
What is claimed is:
1. A method for multiplex insertion of large DNA inserts into a population of cells comprising the steps of: designing and synthesizing a library of integration cassettes with first and second primer handles, wherein each integration cassette comprises 1) a gRNA comprising a scaffold region capable of interacting with a nucleic acid-guided nuclease or nickase fusion enzyme and a guide sequence capable of hybridizing to a genomic target locus of interest; and 2) two portions of a donor DNA, comprising from 5' to 3': a first region of homology to the target locus of interest, the first “primer handle”, the second “primer handle”, and a second region of homology to the target locus of interest; amplifying the library of integration cassettes; inserting the library of integration cassettes into a vector backbone to create an integration vector library; linearizing the integration vectors in the integration vector library using the primer handles; designing and synthesizing a library of large insert constructs, wherein each large insert construct comprises a large insert of interest flanked by regions of homology to the integration cassettes; amplifying the library of large insert constructs; assembling the integration vector library and the large insert constructs creating a library of editing cassettes; transforming the population of cells with the library of editing cassettes; and providing conditions to facilitate editing in the population of cells by the editing cassettes.
2. The method of claim 1, wherein the large insert of interest is at least about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long.
3. The method of claim 1, wherein the large insert of interest is at most about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long.
4. The method of claim 1, wherein the large insert of interest is about 150 to about 250, about 200 to about 300, about 250 to about 350, about 300 to about 400, about 350 to about 450, about 400 to about 500, about 450 to about 550, about 500 to about 600, about 550 to about 650, about 600 to about 700, about 650 to about 750, about 700 to about 800, about 750 to about 850, about 800 to about 900, about 850 to about 950, about 900 to about 1000, about 950 to about 1050, about 1000 to about 1100, about 1050 to about 1150, about 1100 to about 1200, about 1150 to about 1250, about 1200 to about 1300, about 1250 to about 1350, about 1300 to about 1400, about 1350 to about 1450, about 1400 to about 1500, about 1450 to about 1550, about 1500 to about 1600, about 1550 to about 1650, about 1600 to about 1700, about 1650 to about 1750, about 1700 to about 1800, about 1750 to about 1850, about 1800 to about 1900, about 1850 to about 1950, about 1900 to about 2000, about 1950 to about 2050, about 2000 to about 2100, about 2050 to about 2150, about 2100 to about 2200, about 2150 to about 2250, about 2200 to about 2300, about 2250 to about 2350, about 2300 to about 2400, about 2350 to about 2450, about 2400 to about 2500, about 2450 to about 2550, about 2500 to about 2600, about 2550 to about 2650, about 2600 to about 2700, about 2650 to about 2750, about 2700 to about 2800, about 2750 to about 2850, about 2800 to about 2900, about 2850 to about 2950, about 2900 to about 3000, about 2950 to about 3050, about 3000 to about 3100, about 3050 to about 3150, about 3100 to about 3200, about 3150 to about 3250, about 3200 to about 3300, about 3250 to about 3350, about 3300 to about 3400, about 3350 to about 3450, about 3400 to about 3500, about 3450 to about 3550, about 3500 to about 3600, about 3550 to about 3650, about 3600 to about 3700, about 3650 to about 3750, about 3700 to about 3800, about 3750 to about 3850, about 3800 to about 3900, about 3850 to about 3950, about 3900 to about 4000, about 3950 to about 4050, about 4000 to about 4100, about 4050 to about 4150, about 4100 to about 4200, about 4150 to about 4250, about 4200 to about 4300, about 4250 to about 4350, about 4300 to about 4400, about 4350 to about 4450, about 4400 to about 4500, about 4450 to about 4550, about 4500 to about 4600, about 4550 to about 4650, about 4600 to about 4700, about4650 to about 4750, about 4700 to about 4800, about 4750 to about 4850, about 4800 to about 4900, about 4850 to about 4950, or about 4900 to about 5000 bp long.
5. The method of claim 1, wherein the editing cassettes are in circular vectors.
6. The method of claim 1, wherein the editing cassettes are in linear vectors.
7. A method for multiplex insertion of large DNA inserts into a population of cells comprising the steps of: obtaining a library of editing cassettes, wherein each editing cassette comprises 1) a first portion encoding a gRNA comprising a scaffold region capable of interacting with a nucleic acid-guided nuclease or nickase fusion enzyme and a guide sequence capable of hybridizing to a genomic target locus of interest; and 2) three portions of a donor DNA, comprising: a first region of homology to the genomic target locus of interest, a second region of homology to the genomic target locus of interest, and a large insert of interest flanked by the first and second regions of homology; transforming the population of cells with the library of editing cassettes; and providing conditions to facilitate editing in the population of cells by the editing cassettes.
8. The method of claim 7, wherein the large insert of interest is at least about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long.
9. The method of claim 7, wherein the large insert of interest is at most about 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 2000, 3000, 4000 or 5000 bp long.
10. The method of claim 7, wherein the large insert of interest is about 150 to about 250, about 200 to about 300, about 250 to about 350, about 300 to about 400, about 350 to about 450, about 400 to about 500, about 450 to about 550, about 500 to about 600, about 550 to about 650, about 600 to about 700, about 650 to about 750, about 700 to about 800, about 750 to about 850, about 800 to about 900, about 850 to about 950, about 900to about 1000, about 950 to about 1050, about 1000 to about 1100, about 1050 to about 1150, about 1100 to about 1200, about 1150 to about 1250, about 1200 to about 1300, about 1250 to about 1350, about 1300 to about 1400, about 1350 to about 1450, about 1400 to about 1500, about 1450 to about 1550, about 1500 to about 1600, about 1550 to about 1650, about 1600 to about 1700, about 1650 to about 1750, about 1700 to about 1800, about 1750 to about 1850, about 1800 to about 1900, about 1850 to about 1950, about 1900 to about 2000, about 1950 to about 2050, about 2000 to about 2100, about 2050 to about 2150, about 2100 to about 2200, about 2150 to about 2250, about 2200 to about 2300, about 2250 to about 2350, about 2300 to about 2400, about 2350 to about 2450, about 2400 to about 2500, about 2450 to about 2550, about 2500 to about 2600, about 2550 to about 2650, about 2600 to about 2700, about 2650 to about 2750, about 2700 to about 2800, about 2750 to about 2850, about 2800 to about 2900, about 2850 to about 2950, about 2900 to about 3000, about 2950 to about 3050, about 3000 to about 3100, about 3050 to about 3150, about 3100 to about 3200, about 3150 to about 3250, about 3200 to about 3300, about 3250 to about 3350, about 3300 to about 3400, about 3350 to about 3450, about 3400 to about 3500, about 3450 to about 3550, about 3500 to about 3600, about 3550 to about 3650, about 3600 to about 3700, about 3650 to about 3750, about 3700 to about 3800, about 3750 to about 3850, about 3800 to about 3900, about 3850 to about 3950, about 3900 to about 4000, about 3950 to about 4050, about 4000 to about 4100, about 4050 to about 4150, about 4100 to about 4200, about 4150 to about 4250, about 4200 to about 4300, about 4250 to about 4350, about 4300 to about 4400, about 4350 to about 4450, about 4400 to about 4500, about 4450 to about 4550, about 4500 to about 4600, about 4550 to about 4650, about 4600 to about 4700, about 4650 to about 4750, about 4700 to about 4800, about 4750 to about 4850, about 4800 to about 4900, about 4850 to about 4950, or about 4900 to about 5000 bp long.
11. The method of claim 7, wherein the editing cassettes are in circular vectors.
12. The method of claim 7, wherein the editing cassettes are in linear vectors.
13. The method of claim 7, wherein the library of editing cassettes is obtained by assembling an integration vector library and a library of large insert constructs, wherein the integration vector library comprises integration cassettes each comprising 1) the first portion encoding the gRNA; and 2) two portions of the donor DNA, comprising from 5' to 3': the first region of homology to the target locus of interest and the second region of homology to the target locus of interest; and wherein the library of large insert constructs each comprise a large insert of interest flanked by regions of homology to the integration cassettes.
14. The method of claim 7, wherein each of the editing cassettes comprises a unique barcode.
Citation Information
Patent Citations
bilayers
US20140249056A1
Regulation of eucaryotic gene expression
US4833080A
Recombinational cloning using nucleic acids having recombination sites
US6277608B1
Methods and reagents for molecular cloning
US6916632B2
Nuclease-mediated plasmid integration
US20230136423A1
